GLP-1 Family intermediate
GLP-1 Agonist Gastroparesis Management
Clinical management of gastroparesis-like symptoms during GLP-1 agonist therapy.
By Encyclopeptide Editorial | 1 min read
GLP-1 gastroparesis management dose-adjustment GI-tolerability
Management Strategies
Dose Titration
- Start at lowest available dose
- Increase every 4 weeks (not 2 weeks)
- Slower titration reduces GI side effects
Dietary Modification
- Smaller, more frequent meals
- Avoid high-fat, high-fiber foods
- Adequate hydration
- Upright positioning after meals
When to Discontinue
- Persistent vomiting preventing adequate nutrition
- Severe weight loss (>5% body weight)
- Recurrent dehydration
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Gastroparesis Management |
| Category | GLP-1 Family |
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “GLP-1 Agonist Gastroparesis Management” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Gastroparesis Management with interactive quizzes on Wikipept.
Take a Quiz on Wikipept